Atlas
Category: Analytical/Test
Developers: Nirrin Technologies
Product Description:Atlas delivers rapid, on-demand, at-line analysis, revealing blind spots in your bioprocess. Just 15 µL can provide excipient, surfactant, protein, and monoclonal antibody data in one minute at 10X lower cost than current methods. Atlas provides real-time chemical analysis for biomanufacturing, replacing slow, labor-intensive methods such as HPLC. Key uses include optimizing formulations, validating buffers, monitoring upstream processes, and troubleshooting mixing or stability issues. Atlas uses a Nirrin-proprietary high-precision tunable laser spectrometer (HPTLS) in the near-infrared (NIR) region. The laser sweeps across key combination bands (~4000–4600 cm⁻¹), where overtone and combination vibrations of CH, OH, and NH functional groups absorb. Quantitation is performed using proprietary analytical methods built on validated reference libraries. This could replace legacy methods such as HPLC that are slow, labor-intensive, and prone to sample handling errors. Since launching in July 2024, Atlas has been adopted by major pharmaceutical companies for formulation optimization, buffer validation, and upstream process monitoring.
Developers: Nirrin Technologies
Product Description:Atlas delivers rapid, on-demand, at-line analysis, revealing blind spots in your bioprocess. Just 15 µL can provide excipient, surfactant, protein, and monoclonal antibody data in one minute at 10X lower cost than current methods. Atlas provides real-time chemical analysis for biomanufacturing, replacing slow, labor-intensive methods such as HPLC. Key uses include optimizing formulations, validating buffers, monitoring upstream processes, and troubleshooting mixing or stability issues. Atlas uses a Nirrin-proprietary high-precision tunable laser spectrometer (HPTLS) in the near-infrared (NIR) region. The laser sweeps across key combination bands (~4000–4600 cm⁻¹), where overtone and combination vibrations of CH, OH, and NH functional groups absorb. Quantitation is performed using proprietary analytical methods built on validated reference libraries. This could replace legacy methods such as HPLC that are slow, labor-intensive, and prone to sample handling errors. Since launching in July 2024, Atlas has been adopted by major pharmaceutical companies for formulation optimization, buffer validation, and upstream process monitoring.
